BioCorRx (BICX) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.61% |
| Dec 31, 2025 | -11.02% |
| Sep 30, 2025 | 82.62% |
| Mar 31, 2025 | 55.33% |
| Dec 31, 2024 | -20.30% |
| Sep 30, 2024 | -27.41% |
| Jun 30, 2024 | -35.39% |
| Mar 31, 2024 | -46.08% |
| Dec 31, 2023 | -33.21% |
| Sep 30, 2023 | -39.61% |
| Jun 30, 2023 | -47.96% |
| Mar 31, 2023 | -63.50% |
| Dec 31, 2022 | -97.86% |
| Sep 30, 2022 | -695.14% |
| Jun 30, 2022 | -33.36% |
| Mar 31, 2022 | -1.92% |
| Dec 31, 2021 | -6.85% |
| Sep 30, 2021 | -6.29% |
| Jun 30, 2021 | -3.85% |
| Mar 31, 2021 | 7.23% |
| Dec 31, 2020 | 55.82% |
| Sep 30, 2020 | -9.03% |
| Jun 30, 2020 | -16.66% |
| Mar 31, 2020 | 64.21% |
| Dec 31, 2019 | 49.31% |
| Sep 30, 2019 | 26.04% |
| Jun 30, 2019 | 11.36% |
| Mar 31, 2019 | -20.86% |
| Dec 31, 2018 | -26.72% |
| Sep 30, 2018 | -11.06% |
| Jun 30, 2018 | -7.38% |
| Mar 31, 2018 | -213.79% |
| Dec 31, 2017 | -444.52% |
| Sep 30, 2017 | -91.44% |
| Dec 31, 2016 | -237.64% |
| Mar 31, 2016 | -47.63% |
| Dec 31, 2015 | 286.78% |
| Sep 30, 2015 | -47.24% |
| Jun 30, 2015 | -44.62% |
| Mar 31, 2015 | -64.85% |
| Dec 31, 2014 | -55.56% |
| Sep 30, 2014 | -49.33% |
| Dec 31, 2013 | 48.73% |